Gut bugs brew trouble Cell therapy for heart attack: Results still mixedRecent trials enrolled patients days or years after suffering an MI Should CPR guidelines be different in rural areas? Leading edge Toronto Ottawa Heart Summit adds primary care perspective to June agenda Review uncovers deficiencies in patient information on warfarin Assessment finds patient education sheets lack some important content needed for safe use of this drug. Beware high heart rate Bust that clot! STEMI trial touts benefits of pre-hospital fibrinolysis Draw declared in off- versus on-pump CABG trial Results show no differences in one-year outcomes Clot-blocking implant improves safety Device intended as alternative to oral anticoagulants in atrial fibrillation Edarbi and Edarbyclor for hypertension Takeda Canada is introducing a new angiotensin II blocker (ARB) for the treatment of hypertension. First Previous 49 50 51 52 53 Next Last